HIGHLIGHTS
- who: Rosa Jiménez-Lucena from the median follow-up of seven yearsPatients were recruited from November , to February, mostly at the Reina Sofia University Hospital (Córdoba, Spain), but patients from other hospitals from the Córdoba and Jaen provinces were also admitted. In summary, the patients were eligible if they were between , and , years of age, had established CHD without any clinical events in the last , months, were thought to follow a long-term dietary intervention and had no severe diseases or a life expectancy of five years. Details of the trial design were provided . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.